3,905 Shares in Masimo Co. (NASDAQ:MASI) Purchased by RFG Advisory LLC

RFG Advisory LLC bought a new stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 3,905 shares of the medical equipment provider's stock, valued at approximately $645,000.

Other institutional investors and hedge funds have also modified their holdings of the company. NBC Securities Inc. increased its holdings in Masimo by 47.1% in the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider's stock worth $30,000 after buying an additional 73 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Masimo by 180.9% during the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider's stock valued at $32,000 after purchasing an additional 123 shares during the last quarter. Trust Co. of Vermont bought a new position in Masimo during the fourth quarter valued at approximately $33,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Masimo by 133.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 200 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in Masimo by 136.5% in the 4th quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider's stock worth $77,000 after purchasing an additional 269 shares during the period. Institutional investors own 85.96% of the company's stock.

Masimo Price Performance

Shares of MASI stock traded up $0.30 on Monday, hitting $170.54. 437,317 shares of the stock traded hands, compared to its average volume of 518,726. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. Masimo Co. has a 52 week low of $101.61 and a 52 week high of $180.97. The firm has a 50 day simple moving average of $170.32 and a two-hundred day simple moving average of $142.65. The firm has a market cap of $9.13 billion, a price-to-earnings ratio of 117.61 and a beta of 1.01.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, beating the consensus estimate of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The business had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. During the same period in the previous year, the business earned $0.63 earnings per share. The business's revenue was up 5.4% on a year-over-year basis. As a group, equities research analysts predict that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a report on Wednesday, January 22nd. Stifel Nicolaus reissued a "buy" rating and issued a $190.00 target price (up previously from $170.00) on shares of Masimo in a report on Friday, November 22nd. Raymond James boosted their price target on Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a research note on Friday, December 27th. Piper Sandler increased their price objective on shares of Masimo from $180.00 to $210.00 and gave the stock an "overweight" rating in a research note on Wednesday, December 18th. Finally, BTIG Research upped their price objective on Masimo from $166.00 to $170.00 and gave the stock a "buy" rating in a research note on Monday, October 14th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Masimo has a consensus rating of "Moderate Buy" and a consensus target price of $179.67.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.